Making cold malignant pleural effusions hot: driving novel immunotherapies

Making cold malignant pleural effusions hot: driving novel immunotherapies

Malignant pleural effusions, arising from either primary mesotheliomas or secondary malignancies, heralds advanced disease and poor prognosis. Current treatments, including therapeutic thoracentesis and tube thoracostomy, are largely palliative. The immunosuppressive environment within the pleural c...

Celý popis

Podrobná bibliografie
Hlavní autoři: Pranav Murthy, Chigozirim N. Ekeke, Kira L. Russell, Samuel C. Butler, Yue Wang, James D. Luketich, Adam C. Soloff, Rajeev Dhupar, Michael T. Lotze
Médium: Článek
Jazyk:English
Vydáno: Taylor & Francis Group 2019-04-01
Edice:OncoImmunology
Témata:
malignant pleural effusion (mpe)
non-small cell lung cancer (nsclc)
mesothelioma (mm)
damage associated molecular pattern molecules (damps)
cancer immunotherapies
interleukin-2 (il-2)
adoptive cell therapy (act)
On-line přístup:http://dx.doi.org/10.1080/2162402X.2018.1554969

Internet

http://dx.doi.org/10.1080/2162402X.2018.1554969

Podobné jednotky